Ambient Air Pollution and Mortality After Cardiac Transplantation.


Journal

Journal of the American College of Cardiology
ISSN: 1558-3597
Titre abrégé: J Am Coll Cardiol
Pays: United States
ID NLM: 8301365

Informations de publication

Date de publication:
17 12 2019
Historique:
received: 26 03 2019
revised: 26 09 2019
accepted: 30 09 2019
entrez: 24 12 2019
pubmed: 24 12 2019
medline: 23 5 2020
Statut: ppublish

Résumé

Heart transplant recipients are at high risk for mortality, with traditional risk scores performing modestly in predicting post-transplant survival, underscoring the importance of as yet unidentified factors in determining prognosis. In this analysis, the association between PM This study sought to study the association between PM On the basis of the zip code of residence, mortality data in patients who underwent heart transplantation (2004 to 2015) in the United Network for Organ Sharing (UNOS) database were linked with validated estimates of fine particulate matter concentrations (particles with diameter <2.5 μm [PM A total of 21,800 patients with 86,713 patient-years of follow-up was included. Mean age at transplantation was 52.6 ± 12.6 years, 75% were male, 69% were white, and 39% had ischemic etiology of heart failure. Mean annual exposure to PM This study provides evidence linking air pollution with mortality after heart transplantation. These results suggest an important influence of a key environmental factor in outcomes following heart transplantation, and supports the need for further studies in this population.

Sections du résumé

BACKGROUND
Heart transplant recipients are at high risk for mortality, with traditional risk scores performing modestly in predicting post-transplant survival, underscoring the importance of as yet unidentified factors in determining prognosis. In this analysis, the association between PM
OBJECTIVES
This study sought to study the association between PM
METHODS
On the basis of the zip code of residence, mortality data in patients who underwent heart transplantation (2004 to 2015) in the United Network for Organ Sharing (UNOS) database were linked with validated estimates of fine particulate matter concentrations (particles with diameter <2.5 μm [PM
RESULTS
A total of 21,800 patients with 86,713 patient-years of follow-up was included. Mean age at transplantation was 52.6 ± 12.6 years, 75% were male, 69% were white, and 39% had ischemic etiology of heart failure. Mean annual exposure to PM
CONCLUSIONS
This study provides evidence linking air pollution with mortality after heart transplantation. These results suggest an important influence of a key environmental factor in outcomes following heart transplantation, and supports the need for further studies in this population.

Identifiants

pubmed: 31865970
pii: S0735-1097(19)38022-2
doi: 10.1016/j.jacc.2019.09.066
pii:
doi:

Substances chimiques

Particulate Matter 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3026-3035

Subventions

Organisme : NIEHS NIH HHS
ID : R01 ES019616
Pays : United States
Organisme : NIBIB NIH HHS
ID : R01 EB026291
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Sadeer G Al-Kindi (SG)

Harrington Heart and Vascular Institute, University Hospitals, Cleveland, Ohio. Electronic address: https://twitter.com/Sadeer_AlKindi.

Anuja Sarode (A)

College of Public Health, Kent State University, Kent, Ohio.

Melissa Zullo (M)

College of Public Health, Kent State University, Kent, Ohio.

Jeff Brook (J)

School of Public Health, University of Toronto, Ontario, Canada.

Rick Burnett (R)

Health Canada, Ontario, Canada.

Guilherme H Oliveira (GH)

Harrington Heart and Vascular Institute, University Hospitals, Cleveland, Ohio.

Wei Huang (W)

School of Public Health, Peking University, Beijing, China.

Robert Brook (R)

Department of Medicine, University of Michigan, Ann Arbor, Michigan.

Sanjay Rajagopalan (S)

Harrington Heart and Vascular Institute, University Hospitals, Cleveland, Ohio; Case Cardiovascular Research Institute, Case Western Reserve University, Cleveland, Ohio. Electronic address: sanjay.rajagopalan@uhhospitals.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH